| Financial Year |
March 31 2023 |
| Monetary Funds |
2,075,502,104.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
29,296,276.90 |
| Accounts Receivable |
544,398,660.40 |
| Advances to Suppliers |
34,997,285.02 |
| Other Receivables |
1,516,834.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,014,209,255.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,421,480.16 |
| Total Current Assets |
3,785,553,009.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
328,590,222.44 |
| Investment Properties |
19,823,660.72 |
| Fixed Assetes |
1,464,477,714.06 |
| Under-construction Projects |
132,743,792.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
210,577,499.56 |
| R&D expenses |
-- |
| Goodwill |
98,822,520.80 |
| Long-Term Deferred and Prepaid Expenses |
15,934,917.76 |
| Deferred Income Tax Assets |
71,418,159.90 |
| Other Non-Current Assets |
10,080,774.74 |
| Sub-Total of Non-Current Assets |
2,356,645,482.90 |
| Total Assets |
6,142,198,492.04 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
3,611,736.83 |
| Notes Payable |
488,979,751.83 |
| Accounts Payable |
519,781,199.25 |
| Accounts Received In Advance |
619,779.89 |
| Employee Compensation Payable |
162,966,790.30 |
| Taxes Payable |
171,444,651.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
236,942,807.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,935,514.42 |
| Other Current Liabilities |
20,944,348.77 |
| Sub-Total of Current Liabilities |
1,846,603,163.35 |
| Long-term Loans |
602,463,296.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
143,318,567.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
829,734,185.65 |
| Total Liabilities |
2,676,337,349.00 |
| Paid-In Capital(Or Share Stock) |
305,367,100.00 |
| Capital Surplus |
376,182,809.00 |
| Surplus Reserve |
507,064,763.75 |
| LESS:Treasury Stock |
175,960,113.00 |
| Undistributed Profits |
2,459,362,377.70 |
| Minority Stockholder's Interest |
2,767,571.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,463,093,571.42 |
| Owner's Equity（Stockholder's Equity） |
3,465,861,143.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,142,198,492.04 |
